The Guardian - Pharmaceutical Industry

JULY 28, 2022

The authors of a study published in the journal JAMA Oncology on Friday said the lack of transparency should be concerning to Australia. Sign up to receive an email with the top stories from Guardian Australia every morning Continue reading.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies 40

ISPE

MAY 9, 2023

These areas raise the question: How does an area become a hub for competing businesses? Government and business leaders came together with a plan to meet these challenges and, in 1959, created Research Triangle Park (RTP). Every year we encourage new entrepreneurs through our policies and grants for small businesses.”

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Medical Schools 94

ISPE

MARCH 7, 2023

5 , 6 , 7 Failure to properly address the topic of environmental sustainability not only impedes wider efforts to address climate change, but also could have a material impact on the company’s business. This change in mindset will increase pressure in the business. These expectations are defined in various national codes.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

SEPTEMBER 11, 2023

However, it may present increased system and validation complexity, e.g., PAT validation, and any upfront investment in equipment and expertise needs a business justification. Genetic Engineering and Biotechnology News. Sanofi Pumps $554M into New Vaccine Manufacturing Facility in Eastern France.” 36 Sterling, J. 5 October 2022.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

MARCH 6, 2023

Using fewer resources to deliver the same or more output is inherent in pharmaceutical business practices. With rising global demand for energy, doing more with fewer resources is good for the planet, business, and consumers. 5 a b World Resources Institute and World Business Council for Sustainable Development. IEA website.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

MARCH 15, 2023

8 Finally, appropriate environmental sustainability solutions are relative to each business− there is no one-size-fits-all and a life-cost analysis, i.e., to evaluate the economic performance of a building or process over its entire life can be very helpfull. The New Plastics Economy: Rethinking the Future of Plastics.” 30 July 2014.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

Pharmaceutical Technology

APRIL 26, 2023

In the press release, the company announced that Amgen granted Albatroz the first Golden Ticket prize in Singapore for its science and business plan. The Amgen Golden Ticket awards support to early life science businesses by offering them resources for business development.

Communication 102

Communication 102

Pharmaceutical Technology

MARCH 29, 2023

The LSIMF is a £60 million government fund, from the Department for Business, Energy and Industrial Strategy (BEIS), which is meant to support businesses investing in manufacturing projects in the UK. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Communication 110

Communication Vaccines 110

Pharmaceutical Technology

MAY 22, 2023

The news follows Sanofi’s high-profile patent hearing in mid-May – the Supreme Court backing the French biotech giant in its anti-cholesterol drug patent infringement case filed by Amgen after nearly a decade of legal battles. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Vaccines 116

Vaccines Communication 116

ISPE

AUGUST 29, 2022

Final Business Plan Q12: Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management.” 25 US Food and Drug Administration News Release. FDA Advances Data, IT Modernization Efforts with New Office of Digital Transformation.” EMA/CHMP/ICH. Note on EU Implementation of ICH Q12.” Published July 2014.

Documentation 52

Documentation FDA Communication Packaging 52

Pharmaceutical Technology

MAY 3, 2023

In January 2023, Tenaya announced FDA clearance for its Investigational New Drug (IND) application for TN-201. With this recent news, San Francisco-based Tenaya is initiating a multi-centre, open-label Phase Ib clinical trial for the drug. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Mayo Clinic 97

Mayo Clinic FDA Labelling Communication 97

Pharmaceutical Technology

APRIL 18, 2023

This news follows the treatment’s FDA approval on 10 March, making it the first-approved Rett Syndrome treatment in the US. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

FDA 102

FDA Communication 102

Pharmaceutical Technology

APRIL 12, 2023

This news follows Aspect’s announcement last month that it would receive $3.6 As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. million from the Canadian government.

Immunization 93

Immunization Communication 93

Pharmaceutical Technology

MAY 22, 2023

“The new schemes put in place by the government are often replacing, and only partially, European initiatives [that] the UK tech ecosystems thrived on for decades and cannot access anymore,” Pierre Socha, partner in the Early Stage Fund of the venture capital firm Amadeus Capital Partners, writes to this news service.

Vaccines 111

Vaccines Compounding Communication 111

Pharmaceutical Technology

APRIL 12, 2023

While multiple testing labs that use non-human primates for research were contacted for this article, all declined to comment amidst the most recent news coverage. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Vaccines 98

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies 98

Pharmaceutical Technology

MARCH 21, 2023

The ongoing monthly CMO Moves series is outlining the relationship between pharmaceutical and biotech companies, and CMOs using recent news events and clinical trial catalysts. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Packaging 59

Packaging FDA Vaccines Labelling 59

Pharmaceutical Technology

MAY 2, 2023

This news comes a few weeks after BMS signaled an increased focus on cell therapy manufacturing with a takeover of former Novartis plant to boost viral vector production for T-cell therapies. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Communication 52

Communication 52

Pharmaceutical Technology

MARCH 24, 2023

News on this Phase III trial could be released in the next few months, says Dr. Alex Schmidt, Head of Vaccine Development at the Bill and Melinda Gates Medical Research Institute (MRI). “We The Covid vaccines that we have are more than 90% effective, so it’s fantastic news… but we should not stop there,” she says.

Vaccines 64

Vaccines Health and Personal Care Stores Immunization Communication 64

Pharmaceutical Technology

APRIL 4, 2023

In a press release accompanying the recen funding news, Adcendo’s CEO Michael Pehl said, “This financing underscores the confidence that our investors have in Adcendo’s capabilities and potential to develop innovative ADC cancer therapies in high unmet medical need cancers”.

Immunization 52

Immunization Communication 52

Pharmaceutical Technology

APRIL 24, 2023

In an email to this news service, João Conde, PhD, professor at NOVA Medical School, Universidade NOVA de Lisboa, said advances like the mRNA vaccines serve as a testament to the breakthroughs made by science over decades of research at the junction of genetics and nanomedicine.

Vaccines 59

Vaccines Immunization Medical Schools FDA 59

Pharmaceutical Technology

MAY 26, 2023

As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

FDA 52

FDA Adverse Reactions Insurance Communication 52

Pharmaceutical Technology

JANUARY 10, 2023

The acquisition news came as the Annual JP Morgan Healthcare Conference was kickstarted in San Francisco on 9 January. It outweighs the business case”. “We GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry. AstraZeneca will make an upfront payment of $1.3

Communication 98

Communication 98

Pharmaceutical Technology

JANUARY 15, 2023

In the first 2023 edition of the CMO Moves monthly series , Pharmaceutical Technology explores recent news stories on regulatory and reimbursement decisions in different countries, and the companies linked to their success and failures. EMA and NICE news. GlobalData is the parent company of Pharmaceutical Technology. United Kingdom.

Labelling 52

Labelling Packaging FDA Communication 52

Pharmaceutical Technology

JANUARY 25, 2023

News of layoffs and restructuring have evoked concerns that 2023 could be a year of attrition that will push companies to prioritise key candidates and hold onto their finances. While the stock market indices may be down by 40%, the market cap of some companies is down by 90%, leading to news of restructurings and closures, says Ryan.

Communication 69

Communication 69

Pharmaceutical Technology

NOVEMBER 30, 2022

This will support us to maintain manufacturing capacity in the years to come,” said Dr. Avideh Nazeri, Novo Nordisk’s vice president of clinical development, in an email to this news service. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry. United Kingdom. Antarctica.

Insurance 105

Insurance Labelling Communication FDA 105

Pharmaceutical Technology

NOVEMBER 30, 2022

This will support us to maintain manufacturing capacity in the years to come,” said Dr. Avideh Nazeri, Novo Nordisk’s vice president of clinical development, in an email to this news service. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry. United Kingdom. Antarctica.

Insurance 98

Insurance Labelling Communication FDA 98

Pharmaceutical Technology

DECEMBER 4, 2022

Based on recent news reports, UnitedHealth Group’s pharmacy benefit management subsidiary OptumRx will keep Humira on its formulary together with three other biosimilars. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry. United Kingdom. United States. Afghanistan.

Labelling 104

Labelling Communication Hospitals FDA 104

Pharmaceutical Technology

MAY 9, 2023

One of the major strategic projects Jamaels is overseeing at Cerba will eventually bring together all key business processes into a unified and holistic enterprise-wide system. We need a new mindset,” says Jamaels. But we can’t miss the boat on this. You could just see the energy in the room and the ideas kept flowing,” he says.

Vaccines 52

Vaccines Process Improvement Communication 52

Pharmaceutical Technology

JUNE 15, 2023

This news comes at a time when biosimilars are positioned to reduce costs for patients across the board, with industry disruptors bringing more affordable options to the table. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Patient Care 52

Pharmaceutical Technology

FEBRUARY 27, 2023

The ongoing CMO Moves series is exploring the relationship between these CMOs and pharmaceutical and biotech companies that have recently received regulatory news concerning their pipeline assets. GlobalData’s expansive report examines the business environment and trends that shape the Biopharmaceutical industry.

Packaging 52

Packaging Chemotherapy FDA Labelling 52